Mutations in methylenetetrahydrofolate reductase and in cysthationine beta synthase: is there a link to homocysteine levels in peripheral arterial disease?
- 132 Downloads
Peripheral arterial disease (PAD) is an atherosclerotic disturbance characterized by a progressive obstruction of lower limb arteries. Many risk factors associated with PAD development have being reported in the literature. The present study aimed to investigate whether mutations in the methylenetetrahydrofolate reductase (MTHFR) or in the cystathionine beta synthase (CBS) genes are associated with higher levels of homocysteine and the risk of PAD in patients from Brazil. This study analyzed 39 patients with PAD and 32 without PAD in whom risk factors and C677T mutations in the MTHFR gene and both 844ins68 and T833C mutations in the CBS gene were investigated. Although higher levels of homocysteine could be observed in patients with PAD compared to controls, no association between the increase of homocysteine and the frequency of C677T, 844ins68, and T833C mutations could be observed. The results suggest that these mutations do not appear to be related to either homocysteine levels or the development of the disease. However, hyperhomocysteinemia and smoking are important factors in PAD development.
KeywordsPeripheral arterial disease Homocysteine Methylenetetrahydrofolate reductase Cystathionine beta synthase
- 4.TransAtlantic Inter-Society Consensus (TASC) (2000) Management of peripheral vascular disease. Int Angiol 19(Suppl 1):15–28Google Scholar
- 5.Bordeaux LM, Reich LM, Hirsch AT (2003) The epidemiology and natural history of peripheral arterial disease. In: Coffman JD, Eberhardt RT (eds) Peripheral arterial disease diagnosis and treatment. Humana press, New Jersey, pp 21–34Google Scholar
- 9.Asfar S, Safar H (2007) Homocysteine levels and peripheral arterial occlusive disease: a prospective cohort study and review of the literature. J Cardiovasc Surg 48:601–605Google Scholar
- 19.Castro R, Rivera I, Ravasco P, Camilo ME, Jakobs C, Blom HJ et al (2003) 5, 10-Methylenotetrahydrofolate reductase 677C-T and 1298 A-C mutations are genetic determinants of elevated homocysteine. QLM 96:297–303Google Scholar
- 22.Wald DS, Law M, Morris JK (2002) Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325:12002Google Scholar
- 27.Dutta S, Sinha S, Chatoopadhyway A, Gangopadhyay PK, Mukhopadhyay J, Singh M et al (2005) Cystathionine β-synthase T833C/844INS68 polymorphism: a family-based study on mentally retarded children. Behav Brain Funct 26:1–25Google Scholar